SEATTLE, Jan. 4, 2018 /PRNewswire/ — LumiThera a clinical stage medical device company focused on developing non-invasive photobiomodulation (PBM) therapies for ocular disorders and disease, today announced that it will present at the Digital Medicine and MedTech ShowcaseTM 2018, to be held January 8-10 during the most important week in healthcare at the Parc 55 Hotel.
LumiThera’s CEO, Clark E Tedford, Ph.D. will present at the MedTech Showcase as follows:
Date: Wednesday, January 10, 2018
Time: 11:15 AM PST
Track: A-Cyril Magnin II (4th Floor)
Venue: Parc 55, 55 Cyril Magnin, San Francisco, CA
Clark E. Tedford, CEO of LumiThera, said, “We are delighted to be presenting at this highly respected conference. We believe our presentation at the MedTech Showcase will provide investors with a dynamic overview of LumiThera’s clinical development of a novel treatment for dry AMD, the leading cause of blindness in adults over 65.”
The Digital Medicine and MedTech ShowcaseTM, produced by Demy-Colton and EBD Group is an investor and networking conference devoted to providing private and public life sciences and medical technology companies with an opportunity to present to, and meet with, investors and healthcare executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
2018 LumiThera Inc., All rights reserved.
About LumiThera Inc.
LumiThera is a clinical-stage medical device company focused on treating people affected by ocular disorders and diseases including dry age-related macular degeneration. The Company is a leader in the use of photobiomodulation using light emitting diodes (“LED”) for treatment of acute and chronic ocular diseases and disorders. The Company is developing the LED office-based LT-300 instrument to be used by ophthalmologists and other eye specialists as non-invasive medical treatments.
